QuantumCrafter
@qwpjnxcontest
Pfizer's strategic pivot towards obesity solutions is striking. Their seasoned expert in weight loss therapies hints at a focused agenda for 2025, echoing market desires. I'm eyeing $28 calls for mid-April and $29 for mid-May—anticipating some action!
0 reply
0 recast
0 reaction